Casdin Partners Master Fund, L.P.'s Net Worth

$167 Million

Estimate Recalculated Sep 18, 2024 04:46PM EST

Who is Casdin Partners Master Fund, L.P.?

Casdin Partners Master Fund, L.P. has an estimated net worth of $167 Million. This is based on reported shares across multiple companies, which include STANDARD BIOTOOLS INC., CONSTELLATION PHARMACEUTICALS INC, Fulcrum Therapeutics, Inc., Absci Corp, BIOLIFE SOLUTIONS INC, MAXCYTE, INC., GeneDx Holdings Corp., 2seventy bio, Inc., Tenaya Therapeutics, Inc., Verve Therapeutics, Inc., and Decibel Therapeutics, Inc..

SEC CIK

Casdin Partners Master Fund, L.P.'s CIK is 0001534265

Past Insider Trading and Trends

2021 was Casdin Partners Master Fund, L.P.'s most active year for acquiring shares with 9 total transactions. Casdin Partners Master Fund, L.P.'s most active month to acquire stocks was the month of June. 2021 was Casdin Partners Master Fund, L.P.'s most active year for disposing of shares, totalling 4 transactions. Casdin Partners Master Fund, L.P.'s most active month to dispose stocks was the month of June. 2020 saw Casdin Partners Master Fund, L.P. paying a total of $75,363,460.00 for 4,971,536 shares, this is the most they've acquired in one year. In 2022 Casdin Partners Master Fund, L.P. cashed out on 3,971,334 shares for a total of $18,437,940.30, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

STANDARD BIOTOOLS INC. (LAB) Snapshot price: $1.94

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+0.46%
250K
$2.19
$546,750.00
54.03M
Aug 27
Form 4
+0.70%
750K
$2.09
$1,546,237.01
107.4M
Aug 22 - Aug 26
Form 4
+2.37%
1.2M
$1.59
$1,913,520.00
51.78M
Aug 14
Form 4
+3.22%
1.58M
$1.62
$2,559,641.38
50.58M
Aug 9 - Aug 13
Form 4
+1.11%
1.07M
$1.61
$1,718,800.82
97.43M
Aug 7 - Aug 8
Form 4
—
0
$2.05
—
47.28M
Jun 18
Form 4
+0.22%
100K
$2.60
$260,000.00
46.08M
May 23
Form 4
+1.32%
600K
$2.57
$1,541,795.00
45.98M
May 20 - May 22
Form 4
+3.07%
1.35M
$2.56
$3,455,543.67
45.38M
May 15 - May 17
Form 4
+404.12%
46.47M
$2.75
$127,780,009.50
57.96M
Mar 18
Form 4
+2.24%
251.4K
$2.57
$646,168.85
11.5M
Mar 4 - Mar 5
Form 4
∞
13.99M
—
—
13.99M
Jan 5
Form 4
∞
1.2M
$2.19
$2,631,335.00
1.2M
May 17 - May 19
Form 4
—
0
—
—
0
Apr 4
Form 3
—
0
—
—
0
No matching records found

CONSTELLATION PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
771.41K
$15.00
—
771.41K
Jul 23
Form 3
—
0
—
—
0
No matching records found

Fulcrum Therapeutics, Inc. (FULC) Snapshot price: $8.54

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
604.28K
$15.84
—
604.28K
Jul 22
Form 3
—
0
—
—
0
No matching records found

Absci Corp (ABSI) Snapshot price: $4.02

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
7.72M
$16.00
$25,000,000.00
7.72M
Jul 26
Form 3
—
0
—
—
0
No matching records found

BIOLIFE SOLUTIONS INC (BLFS) Snapshot price: $23.79

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$17.54
—
8.71M
Apr 30
Form 4
+12.15%
927.16K
$11.19
$10,374,976.35
8.56M
Oct 19
Form 4
+0.77%
58.47K
$13.20
$771,743.85
7.63M
Aug 9
Form 4
+99.93%
74.97K
$22.32
$1,673,219.91
150K
May 19 - May 22
Form 4/A
+1.77%
131.43K
—
—
7.57M
Sep 1
Form 4
∞
75.03K
$21.26
$1,594,972.98
75.03K
May 16 - May 18
Form 4
+1.70%
126.19K
—
—
7.57M
Sep 1
Form 4
+27.40%
1.6M
$22.50
$36,000,000.00
7.44M
Nov 24
Form 4
+20.43%
990.58K
$14.50
$14,363,453.50
5.84M
Jul 1 - Jul 2
Form 4
+10.89%
476.19K
$10.50
$5,000,005.50
4.85M
May 22
Form 4
+77.16%
1.9M
$10.50
$20,000,001.00
4.37M
May 14
Form 4
+1.65%
40K
$15.41
$616,536.00
2.47M
Nov 19 - Nov 20
Form 3
—
0
—
—
0
No matching records found